AlTi Global’s Apyx Medical APYX Stock Holding History

AlTi Global’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,700	Closed	-$33.3K	–	385
2023 Q4	$33.3K	Buy	+12,700	New	+$30.7K	﹤0.01%	354

Other funds holding APYX

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $211M AUM 58.81% 1-Year Est. Return

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GCA

Greenwood Capital Associates Greenwood, South Carolina $1.02B AUM 28.26% 1-Year Est. Return

AlTi Global's APYX Position: Q1 2024 in Review

AlTi Global sold out of Apyx Medical (APYX) in Q1 2024, closing a stake of 12,700 shares — an estimated $33.3K sold.

AlTi Global first reported a position in APYX in Q4 2023 and held it in 1 quarter. The position peaked at $33.3K in Q4 2023. 51 funds tracked by Wall St. Rank hold APYX as of Q1 2024.

AlTi Global reported no remaining Apyx Medical position as of Q1 2024 after selling out during the quarter.
AlTi Global sold 12,700 Apyx Medical shares in Q1 2024, an estimated $33.3K.
AlTi Global first reported a position in Apyx Medical in Q4 2023 and held it in 1 quarter.
AlTi Global's Apyx Medical position peaked at $33.3K in Q4 2023.
51 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2024.

Based on AlTi Global's 13F filing for Q1 2024, filed 15 May 2024.